# Platelet-rich Plasma in the Treatment of Intractable Postherpetic Neuralgia

> **NCT05444413** · PHASE1 · COMPLETED · sponsor: **Affiliated Hospital of Nantong University** · enrollment: 32 (actual)

## Conditions studied

- PHN - Post-Herpetic Neuritis

## Interventions

- **BIOLOGICAL:** ultrasound-guided platelet rich plasma nerve block

## Key facts

- **NCT ID:** NCT05444413
- **Lead sponsor:** Affiliated Hospital of Nantong University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-03
- **Primary completion:** 2022-05-03
- **Final completion:** 2022-07-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05444413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05444413, "Platelet-rich Plasma in the Treatment of Intractable Postherpetic Neuralgia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05444413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*